Clonal transformation of adult human leukocytes by Epstein-Barr virus.
about
Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants.Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis.Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project.Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase geneEpstein-Barr virus infection of naïve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology.HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytesHuman antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assayAn ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cellsA nonsense mutation in IKBKB causes combined immunodeficiency.Identification of a sub-population of B cells that proliferates after infection with Epstein-Barr virusComparison of Epstein-Barr viral DNAs in Burkitt lymphoma biopsy cells and in cells clonally transformed in vitro.Spinocerebellar ataxia: localization of an autosomal dominant locus between two markers on human chromosome 6.A new variant glyoxalase I allele that is readily detectable in stimulated lymphocytes and lymphoblastoid cell lines but not in circulating lymphocytes or erythrocytesConservation and progressive methylation of Epstein-Barr viral DNA sequences in transformed cells.Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line.Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors.Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains.The 18q- syndrome: analysis of chromosomes by bivariate flow karyotyping and the PCR reveals a successive set of deletion breakpoints within 18q21.2-q22.2.Epstein-Barr virus downregulates microRNA 203 through the oncoprotein latent membrane protein 1: a contribution to increased tumor incidence in epithelial cells.Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA.Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated MalignanciesEpstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase.Mutation deep within an intron of MSH2 causes Lynch syndrome.Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like propertiesSensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell linesDw/LD-related molecular polymorphism of DR4 beta-chains.Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells.Nucleic acid spot hybridization: rapid quantitative screening of lymphoid cell lines for Epstein-Barr viral DNA.Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infectionEpstein-Barr virus DNA is amplified in transformed lymphocytes.A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry.Metabolic stress is a barrier to Epstein-Barr virus-mediated B-cell immortalization.Evaluation of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte responses utilizing B-lymphoblastoid cell lines transduced with the CD4 gene and infected with HIV-1.Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytesMutants of Epstein-Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture.The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
P2860
Q30466290-DE6AD027-5E6B-4097-B1AD-5CCAA91B2C8AQ33720527-6FE4B05E-B29D-4AA4-8A37-DC555B1BA366Q33925373-DF67132E-9B1F-4935-BE79-8032C724ED0CQ34181579-3C7AE2AF-B8B3-47E8-802C-17B5633B548AQ34270452-6FACE685-EFA4-421C-A352-F2014DD0A68AQ34601111-11852D0A-3FF2-469C-A504-5863141ABB60Q34609654-36EEDD43-DF7A-48BB-A5E7-B4C8B79C19A3Q34626894-1D900E3C-EFEF-40AC-B426-7FE638CA0EB4Q34660085-054392E3-52DD-433F-8933-CEF71781592BQ34668808-072D62EB-9484-4C60-960A-2F3C2AA1210CQ35058722-84C7D5F3-6836-4486-A76D-1305249C67E0Q35199455-F0CB0C42-0170-4E1D-AA5A-A624BF3168B8Q35201747-0187BFF7-D53B-4262-8F9A-1F87045D4419Q35237244-BC2DBA99-801F-4579-8B6F-5B5E60C13DBAQ35335767-628C1C82-809A-493E-94AB-70D2A596F5F3Q35382871-D9C34697-0C7E-4BDC-BC08-B97DA6EA735FQ35531692-49528DC9-3901-46FF-B493-A741CB40B9DDQ35643390-CEE2CE10-2BB1-49E6-8C2A-DEABB0C110C1Q35826192-FF3978D4-E3EB-49A0-AE09-7CE87DFCBCD6Q35829364-217D72BF-78B9-43A6-9441-8FC1FE9E0E45Q35829978-EC5F6744-C85F-45F1-97F5-9E45A9E4B930Q35887119-37DC91EA-52B5-47C6-BFF6-B8A44489F141Q36087551-1D97FDCE-3131-409F-8535-F0653088ADCDQ36267648-7E4C6D58-C43A-4DCC-9AD9-248C5B3E2824Q36340233-983A5A10-0705-4133-9DCB-D3D86590CC59Q36347774-244F2616-EDB8-47A1-A860-DC7C521A0FC0Q36365487-E8053FC7-ABE4-442D-91D6-B6E7F46CF179Q36398969-5327196C-BC5A-4F7E-9B36-5D9FC647D752Q36416749-9086CEEA-EA91-4E26-8D79-9A1BE1CB82DEQ36483287-1B13AEFB-64CE-4D2F-911B-DAEEF025E8FBQ36501489-C3CC3AF4-7EDF-4021-9679-1BA0279AF189Q36512734-5A181985-0514-4807-BF7B-70EBFB43EA0AQ36598911-8BC0179D-4F5A-43BB-8651-0D909E9023A7Q36625106-C4038520-DC17-46F0-985B-35A1A966D630Q36633820-0FD66DD4-30FB-4266-8EBD-844A36D9AB1FQ36655549-C5884DB5-F063-4770-8FB9-905C4FF98CC0Q36685081-960CACFC-A806-4D3D-A225-5C90DB595347Q36686042-5BAB28DC-E05E-4A88-A9CB-C535FE6B877BQ36806641-FE54AB92-1BEC-4837-83D1-51144343C28EQ36828608-C6453F68-F5A4-4B11-8F13-D33E5C38431C
P2860
Clonal transformation of adult human leukocytes by Epstein-Barr virus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1977
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clonal transformation of adult human leukocytes by Epstein-Barr virus.
@en
Clonal transformation of adult human leukocytes by Epstein-Barr virus.
@nl
type
label
Clonal transformation of adult human leukocytes by Epstein-Barr virus.
@en
Clonal transformation of adult human leukocytes by Epstein-Barr virus.
@nl
prefLabel
Clonal transformation of adult human leukocytes by Epstein-Barr virus.
@en
Clonal transformation of adult human leukocytes by Epstein-Barr virus.
@nl
P2860
P1433
P1476
Clonal transformation of adult human leukocytes by Epstein-Barr virus.
@en
P2860
P304
P407
P577
1977-09-01T00:00:00Z